James C. Foster is the CEO and Chairman of Charles River Laboratories International, Inc., a major player in the life sciences sector. He has led the company since January 2017, bringing notable experience and a focus on performance-driven leadership. Under...

Current Market Cap

$10.15B

Number of Employees

21.4K

Total Compensation

2019 - 2023

Trending down by -86.23% last year
Showing total compensation for the last 2019 - 2023

Stock

Down by -100.00% last year

Salary

Up by 5.77% last year

Bonus

Up by 0.00% last year

Other

Down by -7.33% last year

Year

2023

Total Compensation

$2.68M

Salary

$1.48M

Board Justification

The compensation program aims to attract and retain top talent while aligning executive interests with shareholder value, focusing on performance-based incentives.

Bonus

$1.13M

Board Justification

The annual cash incentive award is based on performance metrics including revenue and operating income, with a maximum payout of 200% of target based on performance against these metrics for fiscal year 2023.

Other

$71.89K

Board Justification

Includes various benefits such as life insurance, home security expenses, telecommuting benefits, and executive medical expenses.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock grants were vested in 2023 as the focus is on performance share units (PSUs) and stock options which have not yet vested.

Performance Metrics

Performance metrics for the cash bonus include revenue and operating income targets.

SEC Filing

From March 29, 2024

James C. Foster

CEO of Charles River Laboratories

C

Education

Field of Expertise

Healthcare & Life Sciences - Life Sciences

Born

Invalid Date - 0 years ago

Is Founder?

No

Current Tenure

7 years 9 months (Jan 2017 - Present)

Previous Experience

Extensive experience in the life sciences sector, previously served as President of Charles River Laboratories.

View Holdings

Insider Holdings of James C. Foster

CRL

$46.41M

-$10.24M (-18.07%)

Last Insider Trade

CRL

2,500 shares

CRL

Aug 12, 2024

Charity